• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION 213, LLC 0113 CHLORAPREP ONE STEP; 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION 213, LLC 0113 CHLORAPREP ONE STEP; 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL Back to Search Results
Catalog Number 930480NSB
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Rash (2033)
Event Date 06/25/2021
Event Type  Injury  
Manufacturer Narrative
(b)(4) initial emdr submission.A follow up emdr will be submitted if additional information becomes available.(b)(4).
 
Event Description
It was reported that patient developed a rash postoperatively after using the chloraprep.Per complaint details received: nurse inquiring if the bd chloraprep one step applicator has any other inactive ingredients then purified water.They have a patient that developed a rash postoperatively after using the chloraprep.Does not have a product code or lot number for the device used on the patient.States she does have a lot number for the type of chloraprep they use, lot# 0281517.Response: explained we were unable to find any information with the lot number provided.Informed the inactive ingredients for chloraprep one step applicator are as follows: fd&c green #3 dye (scrub-teal applicators only).
 
Manufacturer Narrative
No additional information was provided by the mayo clinic - scottsdale.Primevigilance did reach out to obtain more information with no success.Should additional information be available in the future, the complaint will be re-opened and investigated.Production batch history records for applicator pn 930480nsb lot number 0281517 was reviewed and no non-conformities, failures, deviations, or rework activities occurred during the manufacturing of this lot.Records reviewed indicate that the lot passed all the in-process inspections.All complaints are reviewed during monthly quality/safety meetings.In addition, complaints are trended at monthly quality data analyst meetings and quarterly plant management review meetings.H3 other text : see narrative below.
 
Event Description
It was reported that patient developed a rash postoperatively after using the chloraprep.Per complaint details received: nurse inquiring if the bd chloraprep one step applicator has any other inactive ingredients then purifiedwater.They have a patient that developed a rash postoperatively after using the chloraprep.Does not havea product code or lot number for the device used on the patient.States she does have a lot number for thetype of chloraprep they use, lot# 0281517.Response explained we were unable to find any information with the lot number provided.Informed the inactiveingrdients for chloraprep one step applicator are as follows: fd&c green #3 dye (scrub-teal applicatorsonly).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CHLORAPREP ONE STEP
Type of Device
2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL
Manufacturer (Section D)
CAREFUSION 213, LLC 0113
1550 northwestern dr
el paso TX 79912
MDR Report Key12136031
MDR Text Key260498956
Report Number3004932373-2021-00316
Device Sequence Number1
Product Code KXF
Combination Product (y/n)Y
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,other
Type of Report Initial,Followup
Report Date 08/13/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/08/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/30/2023
Device Catalogue Number930480NSB
Device Lot Number0281517
Date Manufacturer Received08/13/2021
Patient Sequence Number1
Patient Outcome(s) Other;
-
-